Register for our Interactive Virtual Meeting!
HLAA has received permission from the FDA to hold an externally-led Patient-Focused Drug Development Meeting on May 25. It is exciting that HLAA can lead the charge here with the FDA who will attend and listen. Our hope is that patient engagement through a PFDD will go a long way in shaping future hearing loss treatments and creating a deeper understanding of the impact of hearing loss on individuals, their quality of life and associated comorbidities.
PFDD Meeting Registration